Munich biotech with an optical in-ovo sexing method for chicken embryos to avoid culling male chicks.
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Funding round Omegga closes a 10 million euro round with IQ Capital, Capnamic and EIC Fund for commercial scale-up. | $11.6M |
| Sep 2023 | Funding round Munich-based omegga received an undisclosed investment from Rockstart's AgriFood fund for its in-ovo chick sexing technology. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.